
|Videos|April 27, 2022
BioTissue continues the rollout of its corporate rebranding
Author(s)Kassi Filkins
Earlier this year, BioTissue announced the corporate rebrand of its new customer facing entity, including carrying the name over to its surgical business formally known as Amniox Medical. Randy Mansfield, VP of marketing for BioTissue, shares an update at ASCRS 2022.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
Noninvasive LED light therapy shows long-term safety in early cataract clinical follow-up
3
The Residency Report: PreserFlo microshunt vs trabeculectomy—five-year trial insights
4
IGS 2026: The expanding role of artificial intelligence in ophthalmology
5




























